Hyperliquid Strategies (NASDAQ:PURR) Lowered to Sell Rating by Wall Street Zen

Hyperliquid Strategies (NASDAQ:PURR) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Several other research analysts have also issued reports on PURR. Weiss Ratings upgraded Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, June 3rd. Chardan Capital increased their target price on Hyperliquid Strategies from $9.75 to $17.00 and gave the company a “buy” rating in a research note on Friday. Finally, Cantor Fitzgerald set a $22.60 target price on Hyperliquid Strategies and gave the stock an “overweight” rating in a report on Thursday. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $16.53.

Hyperliquid Strategies Price Performance

Shares of Hyperliquid Strategies stock traded down $1.22 on Friday, hitting $11.61. 37,819,591 shares of the company’s stock traded hands, compared to its average volume of 17,643,562. The firm’s 50-day moving average price is $7.86 and its two-hundred day moving average price is $6.88. The stock has a market capitalization of $1.68 billion, a PE ratio of -1.58 and a beta of 1.71. Hyperliquid Strategies has a one year low of $3.01 and a one year high of $14.14.

Institutional Trading of Hyperliquid Strategies

Hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new position in Hyperliquid Strategies in the second quarter valued at about $79,842,000. Paradigm Operations LP acquired a new stake in shares of Hyperliquid Strategies during the fourth quarter worth about $20,327,000. Galaxy Group Investments LLC bought a new position in shares of Hyperliquid Strategies during the 4th quarter valued at about $15,167,000. Pantera Capital Partners LP bought a new position in shares of Hyperliquid Strategies during the 4th quarter valued at about $14,545,000. Finally, Feynman Point Asset Management LLC acquired a new position in shares of Hyperliquid Strategies in the 4th quarter valued at approximately $14,431,000. Institutional investors and hedge funds own 9.45% of the company’s stock.

More Hyperliquid Strategies News

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: Hyperliquid Strategies reported fiscal 2026 net income of approximately $305.5 million and highlighted major operational progress, including more than doubling its HYPE treasury, launching a large network validator and completing its exit from legacy biotech operations. Hyperliquid Strategies Inc Reports Financial Results for the Fiscal Year Ended June 30, 2026
• Positive Sentiment: The company disclosed a HYPE position valued at roughly $1.9 billion, with its treasury reportedly reaching about 29.3 million tokens. Investors appear to be treating the treasury as a direct way to gain exposure to the Hyperliquid ecosystem. Hyperliquid Strategies Shares Rise After Reporting $1.9B HYPE Position
• Positive Sentiment: HYPE reached a record price near $84.80, increasing the reported value of Hyperliquid Strategies’ token holdings and supporting the stock’s momentum. Hyperliquid HYPE Surges to Record $84.80
• Neutral Sentiment: Chardan Capital reaffirmed a Buy rating and raised its outlook, but its reported $9.75 price target is below the stock’s recent trading level, suggesting analysts may be lagging the rally or see limited near-term upside. Why Is Hyperliquid Strategies Stock Up on Friday?
• Negative Sentiment: Technical commentary warns that the HYPE rally may be becoming stretched, while the company’s results and valuation remain highly sensitive to cryptocurrency prices. A reversal in HYPE could reduce the value of PURR’s treasury and pressure the shares. Hyperliquid Price Forecast

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.